Soleno Therapeutics (SLNO) had the highest return between August 1, 2023 and January 5, 2024 by a US stock with a market cap of $2B+, returning 643%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 8/1/2023 - 1/5/2024 | 643% |
QXO (QXO) | 8/1/2023 - 1/5/2024 | 540.91% |
Cytokinetics (CYTK) | 8/1/2023 - 1/5/2024 | 183.26% |
United States Cellular (USM) | 8/1/2023 - 1/5/2024 | 139.81% |
Telephone and Data Systems (TDS) | 8/1/2023 - 1/5/2024 | 139.77% |
Apellis Pharmaceuticals (APLS) | 8/1/2023 - 1/5/2024 | 135.06% |
Abercrombie & Fitch (ANF) | 8/1/2023 - 1/5/2024 | 128.41% |
Scholar Rock (SRRK) | 8/1/2023 - 1/5/2024 | 127.97% |
Affirm (AFRM) | 8/1/2023 - 1/5/2024 | 125.77% |
Biohaven Pharmaceutical (BHVN) | 8/1/2023 - 1/5/2024 | 116.08% |
Alpha Metallurgical Resources (AMR) | 8/1/2023 - 1/5/2024 | 114.13% |
Rhythm Pharmaceuticals (RYTM) | 8/1/2023 - 1/5/2024 | 109.32% |
Immunitybio (IBRX) | 8/1/2023 - 1/5/2024 | 102.29% |
Compania de Minas Buenaventura SAA ADR (BVN) | 8/1/2023 - 1/5/2024 | 96.21% |
Gap (GAP) | 8/1/2023 - 1/5/2024 | 94.82% |
Globalstar, Inc Common Stock (GSAT) | 8/1/2023 - 1/5/2024 | 91.51% |
United States Steel (X) | 8/1/2023 - 1/5/2024 | 91.48% |
Flex (FLEX) | 8/1/2023 - 1/5/2024 | 88.62% |
Immunovant (IMVT) | 8/1/2023 - 1/5/2024 | 87.63% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 8/1/2023 - 1/5/2024 | 87.19% |
Crinetics Pharmaceuticals (CRNX) | 8/1/2023 - 1/5/2024 | 82.95% |
Vertiv (VRT) | 8/1/2023 - 1/5/2024 | 80.51% |
Uranium Energy (UEC) | 8/1/2023 - 1/5/2024 | 77.07% |
CleanSpark (CLSK) | 8/1/2023 - 1/5/2024 | 73.05% |
Pactiv Evergreen (PTVE) | 8/1/2023 - 1/5/2024 | 72.52% |
